HIF1A and neoplasm: Recent studies found that the delivery of the tumor oxidant manganese dioxide nanoparticles (MnO2-NPs) and the HIF-1 functional inhibitor acridine flavonoid (ACF) into tumor tissues using a nanomedicine platform enhanced the effects of radiation therapy and distal effects [167].